BIT’s 4th Annual International Congress of Antibodies (ICA-2012), held in Beijing International Convention Center (BICC) from March 26-28 in Beijing, China has achieved great success. The theme of the conference was “Wining the Race of Antibody R&D”.
More than 100 presentations covering science, technology, business, economics and policy
in the field of antibodies by distinguished scientists and businessmen
Presentation of 100 posters and 30 exhibitions of new products and technologies to an
audience of over 300 people
Round table discussions to create network and marketing opportunities for your business
Career fairs, poster sessions, expositions for both academia and industries
Tour to famous regions of China including Beijing and Xi'an
Keynote Speakers
Dr. Rene Labatut,
Vice President Global Manufacturing Technology, Sanofi Pasteur Inc., France
Dr. Zhengbin (Bing) Yao,
Sr. Vice President, Respiratory, Inflammation, and Autoimmunity, MedImmune, USA
Dr. Raymond E. Spier, President, the International Society for Vaccines, UK
Dr. Yajun Guo, Professor, Second Military Medical University, China
Dr. Robin E. Butler,
Business Development Manager, BTX Harvard Apparatus, USA
Renowned Speakers
Dr. Robert Friesen,
VP, Antibody Discovery, Crucell NV, The Netherlands
Dr. Ralf Ostendorp,VP, Protein Sciences, MorphoSys AG, Germany
Dr. Igor A Kozlov,Senior Director, Assay R&D, Prognosys Biosciences Inc., USA
Dr. Wilfred E. Marissen, Project Director, Crucell Holland BV, The Netherlands
Dr. Titus Kretzschmar , CSO, Delenex Therapeutics AG, Switzerland
Dr. Eszter Nagy, Co-founder & CSO, Arsanis Inc., Austria
Dr. Yan Chen,Senior Vice President, Research, X-BODY BioSciences, USA
Dr. Kuniaki Terato, Director & Founder, Chondrex Inc., USA
Dr. Rong-Hwa Lin, Founder & CEO, AbGenomics International Inc., USA
Dr. Changshou Gao, Principal Scientist, MedImmune LLC., USA
Dr. Peter A. Ward, Professor, University of Michigan Medical School, USA
Dr. Shuangping Shi, Associate Principal Scientist, Merck Sharp & Dohme Corp , USA
Dr. Xiaohua He, Research Molecular Biologist, United States Department of Agriculture, USA
Dr. Nicolas Fischer，Head of Research, NovImmune SA, Switzerland
Dr. Carl K. Edwards,Professor, University of Colorado Denver, USA
Dr. Christopher J. Mann, Global Head, Molecular Devices Biotherapeutics, UK
Dr. C. Michael Neuwelt,Clinical Professor of Medicine, University of California, USA
Dr. Tibor Anderlei, Head, Science and Business Development, Adolf Kühner AG, Switzerland
BIT’s 3rd Annual Congress of Antibodies (ICA-2011) was jointly held with the the 4th Annual Protein and Peptide Conference, the 3rd Annual World Congress of BioSoft as well as the 3rd Annual World Vaccine Congress during March 23-25 in Beijing, China. These conferences achieved great success.
There were more than 500 delegates from 40 countries attended the congress. Meanwhile, as much as 48 exhibitors from home and abroad showed their productions which had became a major attraction during the conference.
Exhibition and Poster
ICA-2012 provides an ideal platform to showcase your new technologies and products in China. It is developed to maximize exposure of exhibitors, with coffee breaks and poster sessions for delegates taking place in the exhibition area.
Why Reserve a Booth at ICA-2012
Meet international leaders in the field of antibody science and technology
Meet key decision makers from around the world
Explore business opportunities in China and beyond
Spotlight your technology and its commercial application
Take advantage of the targeted audience at the conference and network in the exhibition hall.
Johnson & Johnson, USA
Queen's University Belfast, UK
MedImmune LLC, USA
Crucell NV, The Netherlands
MorphoSys AG, Germany
Micromet AG, Germany
Western States Biopharmaceuticals, Inc., USA
GeNeuro SA, Switzerland
Delenex Therapeutics AG, Switzerland
X-BODY BioSciences, USA
Biotherapeutics, UK
DAIICHI SANKYO EUROPE GmbH, Germany
University of Michigan Medical School, USA
University of Liverpool, UK
Adolf Kühner AG, Switzerland
Biosystems International SAS, France
Crystal Bioscience, USA
ProBioGen AG, Germany
Biological Publishing A&O, The Netherlands
NYS Instiute for Basic Research, USA
Anatomical Pathology St.George Hospital UNSW, Australia
ICXT Nomadics, Inc., France
Merck Sharp & Dohme Corp , USA
University of Nantes, France
Texas A&M University, USA
Osaka University, Japan
Asahi Kasei Medical co., ltd., Japan
Australian Biobest Biotechnology Service, Australia
Molecular Devices, China
Defence Research and Development Canada - Suffield, Canada
Medytox Inc., South Korea
Prognosys Biosciences, USA
Royal Bolton Hospital NHS Trust, UK
South Dakota State University, USA
